Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Port Macquarie cleans up after ‘mini-cyclone’ – as it happened

People in NSW town are being urged to stay away from downed power lines. This blog is now closed

The Guardian - AU

U.S. FDA says India-made eye drop linked to some infections, blindness and one death

The U.S. Food and Drug Administration (FDA) has warned against using an eye drop made in India that has been linked to the outbreak of a drug-resistant bacteria leading to adverse events in at least 55 patients in the United States including infections, blindness and one death.

Reuters

Medicare review: what changes can we expect to see - and what’s still missing?

Health sector welcomes the broad vision of taskforce report, but worries it’s short on details, a timeline and money

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses

From July, authorised psychiatrists will be able to prescribe the drugs for post-traumatic stress disorder and severe depression

The Guardian - AU

Restrictions flagged on bulk paracetamol sales

An interim decision by the medicines regulator would prevent Australians from buying packs of up to 100 paracetamol tablets without speaking to a pharmacist.

AAP

Eye drops linked to US drug-resistant bacteria outbreak

U.S. health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections

The Independent UK

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Texas biotech company, UT win $42 million patent case against Boston Scientific

A small Dallas biotech company and the University of Texas took on big pharma and won.

Tribune News Service

Watch: NT alcohol restrictions report, Pharmacy prescribing

Watch: The funeral for controversial Cardinal George Pell is underway. An urgent report into alcohol restrictions in Alice Springs is expected to

The New Daily

Merck COVID drug linked to new virus mutations, study says

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

Tribune News Service

DC boss James Gunn shrugs off 'Shazam' star Zachary Levi's anti-Pfizer tweet

DC boss James Gunn has addressed a controversial tweet from Zachary Levi that called into question the "Shazam!" star's position on vaccines.

Los Angeles Times

GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

The Guardian - UK

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com

Tougher 'intent to supply' meth law to go ahead

The Ministry of Public Health will press ahead with a controversial amendment that would make possession of more than one methamphetamine pill dealing in illegal narcotics.

Bangkok Post

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

Hong Kong bans CBD, with stiff penalties

 A new law criminalising the possession, consumption and selling of cannabidiol (CBD) in Hong Kong came into effect on Wednesday, placing the substance on par with heroin in terms of legal classification.

WEKU

Hong Kong bans CBD, a move that forces businesses to shut down or revamp

Hong Kong banned cannibidiol, also known as CBD, as a "dangerous drug" and imposed harsh penalties for possession on Wednesday, forcing fledging businesses to shut down and revamp.

The Independent UK

Hong Kong bans CBD, forcing businesses to shut or revamp

Hong Kong has banned CBD as a “dangerous drug” and imposed harsh penalties for its possession, forcing fledging businesses to shut down or revamp

The Guardian - AU

Prescription powers and Medicare rebate up for debate as premiers push for healthcare reform

State and territory leaders outline their wishlists before national cabinet meets on Friday

Get all your
news in one place.

100's of premium titles.
One news app.

Birmingham Post

Life science company which works on early cancer therapy and women's health takes space in MediCity Nottingham

New labs will allow team to carry out its own in-house testing, for more efficient and effective drug development

Tribune News Service

Some states may allow nurses to do more without doctors

When COVID-19 hit the United States in 2020, state policymakers across the country jumped to expand access to health care. They temporarily allowed more telehealth, for example, and made it easier for medical providers to practice across state lines.

Dynamite News

Andhra Pradesh: 1 Killed As Reactor Explodes At Pharma Unit In Anakapalli

One person was killed after a reactor exploded at a pharma company in Anakapalli district of Andhra Pradesh on Wednesday. Read further on Dynamite News:

WEKU

AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.

Caixin Global

Shanghai Composite Index Fell 0.42% on Tuesday

Shenzhen Component Index closed down 0.8%

The Guardian - UK

Urgent action needed to curb rise in prison deaths linked to spice, say UK researchers

Synthetic cannabinoids involved in nearly half of male prisoner deaths analysed in England and Wales

The Guardian - UK

Unilever’s new Dutch milkman needs to deliver quickly

Choice of Hein Schumacher means there’s something for everyone in job all about operational execution

1 … 61 62 63 64

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

BristolMyers Squibb Company

95 stories

Ministry of Public Health

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.